Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus.
about
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitusRisk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitusChanging the treatment paradigm for type 2 diabetes.Initial and subsequent therapy for newly diagnosed type 2 diabetes patients treated in primary care using data from a vendor-based electronic health record.Efficacy, safety and cost-effectiveness of insulin sensitizers as add-on therapy in metabolic syndrome in patients with secondary sulfonylurea failure: A comparative studyDurability of oral hypoglycemic agents in drug naïve patients with type 2 diabetes: report from the Swedish National Diabetes Register (NDR).Predictors of insulin initiation in metformin and sulfonylurea users in primary care practices: the role of kidney function.Unmet needs among patients with type 2 diabetes and secondary failure to oral anti-diabetic agents.Optimum management of type 2 diabetes--timely introduction, optimization and intensification of basal insulin.Insulin glargine in type 2 diabetes in everyday clinical practice: 7 years experience.Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy.Evaluating second-line treatment options for type 2 diabetes: focus on secondary effects of GLP-1 agonists and DPP-4 inhibitors.Cyanidin Stimulates Insulin Secretion and Pancreatic β-Cell Gene Expression through Activation of l-type Voltage-Dependent Ca2+ Channels.Insulin versus an oral antidiabetic agent as add-on therapy in type 2 diabetes after failure of an oral antidiabetic regimen: a meta-analysis.Initial sulfonylurea use and subsequent insulin therapy in older subjects with type 2 diabetes mellitusClinical pharmacology of alogliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of Type 2 diabetes.Time to treatment initiation with oral antihyperglycaemic therapy in US patients with newly diagnosed type 2 diabetes.Predictive characteristics of patients achieving glycaemic control with insulin after sulfonylurea failure.
P2860
Q24235718-71BB2347-71FC-4856-990F-A5886773EF07Q24240522-5F70F6C7-ABBC-42C7-AFC9-51E731228A9FQ33610676-631E79C4-30AE-4F20-A6CB-5C9D95930070Q34129085-578AE6C7-0821-4E63-A07A-81187574ECE9Q34595451-30E5B3EF-8588-44D6-9C82-CCA09F744095Q35203980-D3C23487-9231-4855-9275-5027E7A652BFQ35682667-431D341F-5BCB-485B-A09F-81A22859DF39Q37161925-E4E74CE0-DB0C-4081-9580-7E294E95DEB3Q37199304-328B179D-E5C8-4A62-90CD-95316611E416Q37199311-AEE1DB94-167C-4D37-8374-52E45030B30AQ37275660-A402D683-9625-4679-9F19-B7771898B0AAQ38095231-9B476D51-3B10-4BB1-9FA3-B51C2504B5ECQ41583846-8A070FE5-07CC-4B3C-9637-9C108E7B5E2CQ41855774-46CCD946-2B7E-4DEE-B7F8-BFE505BCD582Q42359993-0C170D17-D17D-44C5-90DC-9117A8AAAD72Q42723596-FE1A786F-1173-42B9-8271-6A0C569B8AA9Q44753592-EC71E33E-3C4C-4E03-BA76-4CD95FBCFEA1Q51368086-E7F1AB8A-E1D4-49FF-A9C6-70E0922E512C
P2860
Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Secondary failure rates associ ...... for type 2 diabetes mellitus.
@en
Secondary failure rates associ ...... for type 2 diabetes mellitus.
@nl
type
label
Secondary failure rates associ ...... for type 2 diabetes mellitus.
@en
Secondary failure rates associ ...... for type 2 diabetes mellitus.
@nl
prefLabel
Secondary failure rates associ ...... for type 2 diabetes mellitus.
@en
Secondary failure rates associ ...... for type 2 diabetes mellitus.
@nl
P2093
P2860
P1433
P1476
Secondary failure rates associ ...... for type 2 diabetes mellitus.
@en
P2093
Dean T Eurich
Scot H Simpson
Sumit R Majumdar
P2860
P304
P356
10.1592/PHCO.2005.25.6.810
P407
P577
2005-06-01T00:00:00Z